Brussels, Belgium
July 14, 2005
The European Food Safety Authority Journal (2005) 256, 1-25
Summary of the Opinion
This document provides an
opinion of the Scientific Panel on Genetically Modified
Organisms (GMO Panel) of the European Food Safety Authority
(EFSA) on genetically modified maize MON 863 x MON 810 x NK603
(Unique Identifier MON-ØØ863-5 x MON-ØØ81Ø-6 x MON-ØØ6Ø3-6) to
provide protection against specific lepidopteran and coleopteran
pests and tolerance to the herbicide glyphosate.
In delivering its opinion the Panel considered the application,
additional information provided by the applicant and comments
submitted by the Member States. Further information from
applications for placing the single insert lines on the market
under EU regulatory procedures was taken into account where
appropriate.
MON 863 x MON 810 x NK603 maize was assessed with reference to
the intended uses and the appropriate principles described in
the guidance document of the Scientific Panel on Genetically
Modified Organisms for the risk assessment of genetically
modified plants and derived food and feed. The scientific
assessment included molecular characterisation of the inserted
DNA and expression of target proteins. A comparative analysis of
agronomic traits and composition was undertaken and the safety
of the new proteins and the whole food/feed was evaluated with
respect to toxicity and allergenicity. Both a nutritional and an
environmental assessment, including monitoring plans, were
undertaken.
MON 863 maize was developed to provide protection against
certain coleopteran pests, principally corn rootworm (Diabrotica
spp.) by the introduction of a variant Bacillus thuringiensis
cry3Bb1 gene expressing an insecticidal protein. MON 863 has
received an EFSA opinion in favour of its authorisation. MON 810
maize produces the protein Cry1Ab, which confers protection
against certain lepidopteran insect pests (Ostrinia nubilalis
and Sesamia spp.). MON 810 was approved under Directive
90/220/EEC by Commission Decision 98/294/EC. The use of food
ingredients from MON 810 maize was notified in 1997 under
Regulation (EC) No 258/97. NK603 was developed to be tolerant to
the herbicide glyphosate by the introduction of a gene coding
for 5-enoylpyruvylshikimate-3-phosphate synthase from
Agrobacterium sp. strain CP4 (CP4 EPSPS). NK603 has received an
opinion in favour of its authorisation and was authorised under
Directive 2001/18/EC by Commission Decision 2004/643/EC. The use
of food and food ingredients from NK603 maize were authorised
under the Regulation (EC) No 258/97 by Commission Decision
2005/448/EC.
MON 863 x MON 810 x NK603 maize was produced by crosses between
maize inbred lines containing MON 863, MON 810 and NK603 events
to combine the rootworm resistance trait in MON 863 with the
trait present in MON 810 protecting against lepidopteran pests
and the tolerance to the herbicide glyphosate in NK603.
Molecular analysis of the DNA inserts present in the MON 863 x
MON 810 x NK603 maize confirmed that the insert structures of
the single events were retained.
Cry3Bb1, Cry1Ab and CP4 EPSPS protein levels in kernels of the
MON 863 x MON 810 x NK603 maize were comparable to the
individual MON 863, MON 810 and NK603 lines.
The safety of the Cry3Bb1, Cry1Ab, CP4 EPSPS and NptII proteins
has previously been assessed in the single events for which
positive opinions were issued.
MON 863 x MON 810 x NK603 maize was found to contain transgenic
proteins associated with the introduced transgenic traits of
insect- and herbicide-resistance. Besides these deliberate
changes, this maize showed no marked alterations in composition,
agronomy and phenotype compared with the control lines and
reference lines. The Panel therefore concludes that MON 863 x
MON 810 x NK603 maize is compositionally and phenotypically
equivalent to its parental single-trait GM lines and
non-genetically modified maize, except for the introduced
traits.
A 90 day sub chronic rodent study with MON 863 x MON 810 x NK603
maize indicated that there are no adverse effects from its
consumption.
Feeding studies conducted on broilers with MON 863 x MON 810 x
NK603 maize showed no adverse effects. The Panel considers that
the nutritional properties of this maize would be no different
from those of conventional maize.
The application EFSA GMO BE 2004 07 concerns food and feed uses
and import and processing. There is therefore no requirement for
scientific information on possible environmental effects
associated with the cultivation of the maize lines. The GMO
Panel agrees that unintended environmental effects due to the
establishment and spread of GM maize will not be different from
that of traditionally bred maize. The monitoring plan provided
by the applicant is in line with the intended uses for the GMO.
In conclusion, the Panel considers that the information
available for MON 863 x MON 810 x NK603 maize addresses the
outstanding questions raised by the Member States and considers
that it will not have adverse effects on human and animal health
or the environment in the context of its proposed use.
Opinion in PDF format:
http://www.efsa.eu.int/science/gmo/gmo_opinions/1033/gmo_opinion_ej256_mon863xmon810xnk603_en1.pdf
|